Molecular Events Initiating B Cell Fate Determination

描述（由申请人提供）：B淋巴细胞是关键的血细胞，其产生或功能改变可导致严重疾病。我们有兴趣了解造血干细胞如何启动B细胞发育。阐明正常的B细胞发育途径将有助于深入了解许多血液病的分子和细胞基础。虽然在了解幼稚B细胞从定型B细胞前体的产生方面已经取得了相当大的进展，但对这一过程如何开始知之甚少。该项目将利用令人兴奋的新发现，关于受体酪氨酸激酶Flt 3，HoxA蛋白和B细胞命运决定因子EBF之间的意想不到的调节连接。我们的新数据表明，这种调节连接在调节干细胞向Pro-B转化中起着重要作用，因此，产生的B淋巴细胞的数量。具体来说，我们将了解Flt 3信号如何启动一系列事件，逐渐将骨髓中的多能祖细胞偏向B谱系。令人兴奋的新数据显示，Flt 3信号，在配体剂量依赖性的方式，调节活性的主要B细胞的命运决定因素，E2 A，EBF基因的关键调节。一旦表达，EBF协调B细胞分化。EBF-/-细胞系的基因表达谱分析指出EBF在B细胞发育过程中的新作用，即控制发育调节的HoxA蛋白簇的表达。阐明控制HoxA表达的调节回路是重要的，因为失调的表达损害B细胞分化。首先，我们将确定Flt 3信号转导和EBF表达之间的分子事件。然后，我们将确定EBF，HoxA和Flt 3之间的调节连接，控制B淋巴细胞的产生。总的来说，这些实验将提供一个重要过程的基本知识，即产生白色血细胞，使抗体对抗感染。这些信息应该有助于确定干预血细胞癌和免疫缺陷疾病的分子靶点。公共卫生相关性：在血细胞发育过程中，干细胞向前B细胞的转化是控制B细胞稳态的关键检查点。该项目的重点是确定三个关键因素，受体酪氨酸激酶Flt 3，HoxA蛋白，和B细胞命运决定因子EBF，协调这一关键检查点的分子电路。

DESCRIPTION (provided by applicant): B lymphocytes are critical blood cells and altered production or function can cause significant disease. We are interested in understanding how blood stem cells initiate B cell development. Delineating the normal B cell developmental pathway will provide insight into the molecular and cellular basis of many hematologic diseases. Although considerable progress has been made in understanding the generation of naive B cells from committed B cell precursors, little is known about how this process begins. This project will exploit exciting new findings concerning an unexpected regulatory connection between the receptor tyrosine kinase Flt3, HoxA proteins, and the B cell fate determinant EBF. Our new data suggest that this regulatory connection plays an important role in regulating the stem cell to Pro-B transition, and hence, the numbers of B lymphocytes generated. Specifically, we will learn how Flt3 signaling initiates a series of events, gradually biasing multipotential progenitors in bone marrow into the B lineage. Exciting new data revealed that Flt3 signaling, in a ligand-dose dependent fashion, regulates the activity of the primary B cell fate determinant, E2A, a key regulator of the EBF gene. Once expressed, EBF orchestrates B cell differentiation. Gene expression profiling of an EBF-/- cell line pointed to novel role for EBF during B cell development, namely controlling expression of a developmentally regulated cluster of HoxA proteins. Elucidating regulatory circuits that control HoxA expression is important, as dysregulated expression impairs B cell differentiation. First we will determine the molecular events between Flt3 signaling and EBF expression. Then we will determine the regulatory connection between EBF, HoxA, and Flt3 that controls the production of B lymphocytes. Overall, these experiments will provide basic knowledge of a vital process, the production of white blood cells that make antibodies to fight infections. The information should help identify molecular targets for intervention in blood cell cancers and immunodeficiency diseases. PUBLIC HEALTH RELEVANCE: During blood cell development, the stem cell to Pro-B transition is a pivotal checkpoint that controls B cell homeostasis. This project focuses on determining the molecular circuitry through which three critical factors, the receptor tyrosine kinase Flt3, HoxA proteins, and the B cell fate determinant EBF, orchestrate this critical checkpoint.